{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:02:37Z","timestamp":1784862157236,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006271.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T00:00:00Z","timestamp":1446422400000}}],"reference-count":100,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006271.pub3","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T09:17:24Z","timestamp":1446455844000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Haloperidol for the treatment of nausea and vomiting in palliative care patients"],"prefix":"10.1002","volume":"2020","author":[{"given":"Fay","family":"Murray-Brown","sequence":"additional","affiliation":[{"name":"Speciality Training Programme in Palliative Medicine; Peninsula Deanery; Devon UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskie","family":"Dorman","sequence":"additional","affiliation":[{"name":"Palliative Medicine; Poole Hospital NHS Foundation Trust; Poole UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,2]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD006271.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jpainsymman.2014.02.010","article-title":"A randomized trial of the effectiveness of eopical \"ABH Gel\" (Ativan\u00ae, Benadryl\u00ae, Haldol\u00ae) vs. placebo in cancer patients with nausea","volume":"48","author":"Fletcher","year":"2014","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD006271.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exphem.2007.01.010","article-title":"Management of radiation-induced nausea and vomiting","volume":"35","author":"Abdelsayed","year":"2007","journal-title":"Experimental Haematology"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0003|cit3","first-page":"27","article-title":"Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea and vomiting: Results of two pilot trials","volume":"6","author":"Bleicher","year":"2008","journal-title":"Journal of Supportive Oncology"},{"issue":"5","key":"10.1002\/14651858.CD006271.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0277-5379(91)90217-2","article-title":"Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy","volume":"27","author":"Bregni","year":"1991","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/00000542-200412000-00028","article-title":"Is low-dose haloperidol a useful antiemetic? A meta-analysis of published and unpublished randomized trials","volume":"101","author":"Buttner","year":"2004","journal-title":"Anaesthesiology"},{"issue":"7","key":"10.1002\/14651858.CD006271.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1586\/era.11.83","article-title":"Symptom management in gynaecologic malignancies","volume":"11","author":"Casey","year":"2011","journal-title":"Expert Review of Anticancer Therapy"},{"issue":"8","key":"10.1002\/14651858.CD006271.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.12968\/ijpn.2000.6.8.9060","article-title":"Hypodermoclysis for control of dehydration in terminal-stage cancer","volume":"6","author":"Cerchietti","year":"2000","journal-title":"International Journal of Palliative Nursing"},{"issue":"3","key":"10.1002\/14651858.CD006271.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1053\/j.seminoncol.2011.03.016","article-title":"Pharmacologic management of cancer-related pain, dyspnoea and nausea","volume":"38","author":"Cheung","year":"2011","journal-title":"Seminars in Oncology"},{"issue":"6","key":"10.1002\/14651858.CD006271.pub3-BIB0009|cit9","first-page":"342","article-title":"Update on antiemetics of chemotherapy","volume":"18","author":"Chiu","year":"2007","journal-title":"Journal of Internal Medicine of Taiwan"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/CEG.S6554","article-title":"Acute gastroenteritis: from guidelines to real life","volume":"3","author":"Chow","year":"2010","journal-title":"Clinical and Experimental Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD006271.pub3-BIB0011|cit11","first-page":"1171","article-title":"Low-dose haloperidol as antiemetic treatment in gastrointestinal disorders: a double-blind study","volume":"16","author":"Christman","year":"1974","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0889-8537(03)00087-7","article-title":"Opioid effectiveness and side effects in chronic pain","volume":"21","author":"Christo","year":"2003","journal-title":"Anesthesiology Clinics of North America"},{"issue":"12","key":"10.1002\/14651858.CD006271.pub3-BIB0013|cit13","first-page":"1059","article-title":"Pharmacologic pearls for end of life care","volume":"79","author":"Clary","year":"2009","journal-title":"American Family Physician"},{"issue":"9","key":"10.1002\/14651858.CD006271.pub3-BIB0014|cit14","first-page":"1558","article-title":"Haloperidol for radiation sickness: control of associated nausea, vomiting, and anorexia","volume":"74","author":"Cole","year":"1974","journal-title":"New York State Journal of Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0885-3924(94)90147-3","article-title":"Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer","volume":"9","author":"Cole","year":"1994","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD006271.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jpainsymman.2009.08.010","article-title":"A systematic review of the treatment of nausea and\/or vomiting in cancer unrelated to chemotherapy of radiation","volume":"39","author":"Davis","year":"2010","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0017|cit17","first-page":"1766","article-title":"A double-blind cross-over clinical valuation of metoclopramide and a combination of haloperidol and isopropamide iodide in gastroenterology","volume":"19","author":"De Vries","year":"1969","journal-title":"Arzneimittel-Forschung"},{"issue":"6","key":"10.1002\/14651858.CD006271.pub3-BIB0018|cit18","first-page":"378","article-title":"Prevention and treatment of chemotherapy-induced nausea and vomiting","volume":"42","author":"DiVall","year":"2007","journal-title":"Formulary"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.6004\/jnccn.2007.0004","article-title":"Antiemesis: clinical practice guidelines in oncology","volume":"5","author":"Ettinger","year":"2007","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"5","key":"10.1002\/14651858.CD006271.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.6004\/jnccn.2009.0039","article-title":"Antiemesis","volume":"7","author":"Ettinger","year":"2009","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/annonc\/mdq600","article-title":"Update and new trends in antiemetic therapy: the continuing need for novel therapies","volume":"22","author":"Feyer","year":"2011","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006271.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0959-8049(93)90374-O","article-title":"A randomised cross-over trial of antiemetic therapy for platinum-based chemotherapy. Improved control with an intensive multiagent regimen","volume":"29A","author":"Findlay","year":"1993","journal-title":"European Journal of Cancer"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0023|cit23","first-page":"73","article-title":"Randomised controlled trial of three antiemetics in the emergency department","volume":"21","author":"Fischberg","year":"2007","journal-title":"Journal of Pain and Palliative Care Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD006271.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.emc.2011.01.005","article-title":"Vomiting, diarrhoea, constipation and gastroenteritis","volume":"29","author":"Getto","year":"2011","journal-title":"Emergency Medicine Clinics of North America"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0025|cit25","first-page":"432","article-title":"Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer","volume":"12","author":"Glare","year":"2004","journal-title":"Supportive Care Cancer"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0026|cit26","first-page":"243","article-title":"Treating nausea and vomiting in palliative care: a review","volume":"6","author":"Glare","year":"2011","journal-title":"Clinical Interventions in Ageing"},{"issue":"2","key":"10.1002\/14651858.CD006271.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cger.2011.01.006","article-title":"Nausea and other nonpain symptoms in long-term care","volume":"27","author":"Gonzales","year":"2011","journal-title":"Clinics in Geriatric Medicine"},{"issue":"7","key":"10.1002\/14651858.CD006271.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1200\/JCO.1984.2.7.782","article-title":"Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study","volume":"2","author":"Grunberg","year":"1984","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s00520-009-0807-z","article-title":"Chemotherapy-induced nausea and vomiting: contemporary approaches to optimal management","volume":"18 Suppl 1","author":"Grunberg","year":"2010","journal-title":"Supportive Care in Cancer"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpainsymman.2009.11.321","article-title":"The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer","volume":"40","author":"Hardy","year":"2010","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1592\/phco.22.3.240.33552","article-title":"Management of opioid-induced gastrointestinal effects in patients receiving palliative care","volume":"22","author":"Herndon","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ncponc1021","article-title":"Antiemetics: an update and the MASCC guidelines applied in clinical practice","volume":"5","author":"Herrstedt","year":"2008","journal-title":"Nature Clinical Practice Oncology"},{"issue":"2","key":"10.1002\/14651858.CD006271.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.critrevonc.2006.08.003","article-title":"Comparative activity of anti-emetic drugs","volume":"61","author":"Jordan","year":"2007","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/jpm.2005.8.20","article-title":"Sedation for terminally ill patients with cancer with uncontrollable physical distress","volume":"8","author":"Kohara","year":"2005","journal-title":"Journal of Palliative Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000016917","article-title":"Novel approaches to the treatment of nausea and vomiting","volume":"17","author":"Ladabaum","year":"1999","journal-title":"Digestive Diseases"},{"issue":"11","key":"10.1002\/14651858.CD006271.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1177\/0269881109358200","article-title":"Central nervous system effects of haloperidol on THC in healthy male volunteers","volume":"24","author":"Liem-Moolenaar","year":"2010","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006271.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/PPO.0b013e31816a0f07","article-title":"Chemotherapy-induced nausea and vomiting","volume":"14","author":"Lohr","year":"2008","journal-title":"Cancer Journal"},{"issue":"2","key":"10.1002\/14651858.CD006271.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pop.2011.03.005","article-title":"Assessment of gastrointestinal symptoms in advanced illness","volume":"38","author":"McHugh","year":"2011","journal-title":"Primary Care - Clinics in Office Practice"},{"issue":"5","key":"10.1002\/14651858.CD006271.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1526-5900(03)00556-X","article-title":"Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review","volume":"4","author":"McNicol","year":"2003","journal-title":"Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD006271.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpainsymman.2006.06.014","article-title":"Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review","volume":"33","author":"Mercadante","year":"2007","journal-title":"Journal of Pain and Symptom Management"},{"issue":"23","key":"10.1002\/14651858.CD006271.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1200\/JCO.2007.15.9533","article-title":"Evidence-based recommendations for cancer nausea and vomiting","volume":"26","author":"Naeim","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0042|cit42","first-page":"3","article-title":"Overview of the updated antiemetic guidelines for chemotherapy-induced nausea and vomiting","volume":"4 Suppl 1","author":"Navari","year":"2007","journal-title":"Community Oncology"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/1097-0142(19810315)47:6<1439::AID-CNCR2820470633>3.0.CO;2-#","article-title":"Specific antiemetics for specific cancer chemotherapeutic agents: haloperidol versus benzquinamide","volume":"47","author":"Neidhart","year":"1981","journal-title":"Cancer"},{"issue":"14","key":"10.1002\/14651858.CD006271.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1517\/14656566.2011.597382","article-title":"Pharmacological treatment of bowel obstruction in cancer patients","volume":"12","author":"O'Connor","year":"2011","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0045|cit45","first-page":"167","article-title":"Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis","volume":"3","author":"Owens","year":"1984","journal-title":"Clinical Pharmacy"},{"issue":"2","key":"10.1002\/14651858.CD006271.pub3-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006271.pub2","article-title":"Haloperidol for the treatment of nausea and vomiting in palliative care patients","author":"Perkins","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD006271.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.mpaic.2009.08.012","article-title":"Physiology and pharmacology of nausea and vomiting","volume":"10","author":"Pleuvry","year":"2009","journal-title":"Anaesthesia and Intensive Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006271.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1526-4637.2009.00583.x","article-title":"Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: Mechanisms, implications and management options","volume":"10","author":"Porreca","year":"2009","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s005200000198","article-title":"Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer","volume":"9","author":"Ripamonti","year":"2001","journal-title":"Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1532-5415.1975.tb00378.x","article-title":"Haloperidol parenterally for treatment of vomiting and nausea from gastrointestinal disorders in a group of geriatric patients: double-blind, placebo-controlled study","volume":"23","author":"Robbins","year":"1975","journal-title":"Journal of the American Geriatrics Society"},{"issue":"3","key":"10.1002\/14651858.CD006271.pub3-BIB0051|cit51","first-page":"100","article-title":"Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 1: Physical symptoms","volume":"8","author":"Roeland","year":"2010","journal-title":"Journal of Supportive Oncology"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF01733669","article-title":"The benefit and risk of high dose metoclopramide in comparison to high dose haloperidol or trifluorpromazine in cisplatin-induced emesis","volume":"63","author":"Saller","year":"1985","journal-title":"Klinische Wochenschrift"},{"issue":"3","key":"10.1002\/14651858.CD006271.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jpainsymman.2007.10.001","article-title":"Haloperidol as a palliative anti-emetic in a toddler: an evidence-base challenge","volume":"35","author":"Siden","year":"2008","journal-title":"Journal of Pain and Symptom Management"},{"issue":"9","key":"10.1002\/14651858.CD006271.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1200\/JCO.1988.6.9.1397","article-title":"A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea\u00a0and vomiting in patients receiving chemotherapy for breast cancer","volume":"6","author":"Silvey","year":"1988","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"Abstract 9021","DOI":"10.1200\/jco.2011.29.15_suppl.9021","article-title":"Testing the cutaneous absorption of lorazepam, diphenhydramine and haloperidol gel (ABH gel) used for cancer-related nausea","volume":"29","author":"Smith","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0056|cit56","unstructured":"Smith T Fletcher D Coyne P Dodson P Parker G ABH gel is not absorbed from the skin of normal volunteer so cannot be effective against nausea Journal of Pain and Symptom Management. Conference: Annual Assembly of the American Academy of Hospice and Palliative Medicine and the Hospice and Palliative Nurses Association Denver, US 2012"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0057|cit57","first-page":"22","article-title":"A review of the 2006 ASCO antiemetic guidelines update","volume":"32","author":"Sperry","year":"2007","journal-title":"US Pharmacist"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.giec.2008.12.008","article-title":"Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics","volume":"19","author":"Stapleton","year":"2009","journal-title":"Gastrointestinal Endoscopy Clinics of North America"},{"issue":"4","key":"10.1002\/14651858.CD006271.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/15360280903332179","article-title":"Haloperidol for nausea and vomiting","volume":"23","author":"Tatum","year":"2009","journal-title":"Journal of Pain and Palliative Care Pharmacotherapy"},{"issue":"6","key":"10.1002\/14651858.CD006271.pub3-BIB0060|cit60","first-page":"1024","article-title":"Haloperidol as an antiemetic - guest discussion","volume":"50","author":"Tornetta","year":"1971","journal-title":"Anesthesia and Analgesia - Current Researches"},{"issue":"6","key":"10.1002\/14651858.CD006271.pub3-BIB0061|cit61","first-page":"964","article-title":"Double-blind evaluation of haloperidol for antiemetic activity. Anesthesia and analgesia","volume":"51","author":"Tornetta","year":"1972","journal-title":"Current Researches"},{"issue":"8","key":"10.1002\/14651858.CD006271.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/bmt.2008.257","article-title":"Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens","volume":"42","author":"Trigg","year":"2008","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD006271.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1078155209354655","article-title":"Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice","volume":"16","author":"Trigg","year":"2010","journal-title":"Journal of Oncology Pharmacy Practice"},{"issue":"6","key":"10.1002\/14651858.CD006271.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1089\/jpm.2005.8.1135","article-title":"Tolerability of the compound ABHR in hospice patients","volume":"8","author":"Weschules","year":"2005","journal-title":"Journal of Palliative Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1191\/0269216306pm1118cr","article-title":"Prolonged extra-pyramidal side effects after discontinuation of haloperidol as an antiemetic","volume":"20","author":"White","year":"2006","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0066|cit66","unstructured":"Hardy J Yates P Philip J Martin P Glare P Currow D A targeted versus empiric approach to antiemetic use in advanced cancer In: MASCC\/ISOO International Symposium on Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0067|cit67","unstructured":"Yates P The effectiveness of guideline driven antiemetic therapy versus single agent antiemetic therapy in patients with cancer and nausea not related to cancer therapy Australian New Zealand Clinical Trials Registry 2010 https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12610000481077"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0068|cit68","unstructured":"Hardy JR A randomised, controlled, double blind study of oral methotrimeprazine versus oral haloperidol in patients with cancer and nausea not related to anticancer therapy (Nausea study 3), to compare the effectiveness of oral methotrimeprazine versus oral haloperidol in improving the management of nausea in patients with cancer and nausea not related to anticancer therapy World Health Organization International Clinical Trials Registry Platform http:\/\/www.anzctr.org.au\/ACTRN1261500077550.aspx"},{"issue":"4","key":"10.1002\/14651858.CD006271.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00000542-197504000-00028","article-title":"The use of haloperidol for treatment of postoperative nausea and vomiting--a double-blind placebo-controlled trial","volume":"42","author":"Barton","year":"1975","journal-title":"Anesthesiology"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1191\/026921601678576239","article-title":"Use of clinical pictures in the management of nausea and vomiting","volume":"15","author":"Bentley","year":"2001","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0885-3924(01)00323-2","article-title":"Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative patient: a systematic review","volume":"22","author":"Critchley","year":"2001","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1191\/026921601678320278","article-title":"A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer","volume":"15","author":"Edmonds","year":"2001","journal-title":"Palliative Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006271.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.annemergmed.2014.03.017","article-title":"Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo","volume":"64","author":"Egerton-Warburton","year":"2014","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1191\/0269216304pm905oa","article-title":"Recruiting patients into a primary care based study of palliative care: why is it so difficult?","volume":"18","author":"Ewing","year":"2004","journal-title":"Palliative Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006271.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/026921639701100514","article-title":"Placebo-controlled trials in palliative care: the argument for","volume":"11","author":"Hardy","year":"1997","journal-title":"Palliative Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD006271.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006271.pub3-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003346","article-title":"Benzodiazepines and related drugs for insomnia in palliative care","author":"Hirst","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1191\/026921699668963873","article-title":"Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial","volume":"13","author":"Jordhoy","year":"1999","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0080|cit80","first-page":"2406","article-title":"Nausea and vomiting in people with cancer and other chronic diseases","volume":"06","author":"Keeley","year":"2007","journal-title":"BMJ Clinical Evidence"},{"issue":"6","key":"10.1002\/14651858.CD006271.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/026921639701100611","article-title":"Placebo-controlled trials in palliative care: the argument against","volume":"11","author":"Kirkham","year":"1997","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jpainsymman.2003.05.008","article-title":"Symptom burden in the last week of life","volume":"27","author":"Klinkenberg","year":"2004","journal-title":"Journal of Pain and Symptom Management"},{"issue":"10","key":"10.1002\/14651858.CD006271.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2193::AID-CNCR22>3.0.CO;2-T","article-title":"Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin","volume":"78","author":"Kris","year":"1996","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/jpm.2012.0205","article-title":"Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion","volume":"16","author":"Lindqvist","year":"2013","journal-title":"Journal of Palliative Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L\u2019Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0086|cit86","volume-title":"Oxford Textbook of Palliative Medicine","author":"Mannix","year":"2004"},{"issue":"2","key":"10.1002\/14651858.CD006271.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/15360288.2013.782937","article-title":"Using haloperidol as an antiemetic in palliative care: informing practice through evidence from cancer treatment and postoperative contexts","volume":"27","author":"McLean","year":"2013","journal-title":"Journal of Pain and Palliative Care Pharmacotherapy"},{"issue":"7","key":"10.1002\/14651858.CD006271.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1592\/phco.28.7.875","article-title":"Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration","volume":"28","author":"Miller","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0089|cit89","unstructured":"Pereira J Study comparing olanzapine with haloperidol for the relief of nausea and vomiting in patients with advanced cancer clinicaltrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00124930?term=Haloperidol&rank=59"},{"issue":"4","key":"10.1002\/14651858.CD006271.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1049909111423094","article-title":"Role of haloperidol in palliative medicine: an update","volume":"29","author":"Prommer","year":"2012","journal-title":"American Journal of Hospice and Palliative Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1001\/archinte.1986.00360220187030","article-title":"Nausea and vomiting in terminal cancer patients","volume":"146","author":"Reuben","year":"1986","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0092|cit92","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"5","key":"10.1002\/14651858.CD006271.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jpainsymman.2012.12.005","article-title":"Placebo and nocebo effects in randomized controlled trials: the implications for research and practice","volume":"46","author":"Sanderson","year":"2013","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0094|cit94","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD006271.pub3-BIB0095|cit95","first-page":"137","article-title":"Dopamine receptor antagonists","volume":"1","author":"Smith","year":"2012","journal-title":"Annals of Palliative Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006271.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpainsymman.2005.06.007","article-title":"A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease","volume":"31","author":"Solano","year":"2006","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1010389215197","article-title":"Clinical management of neuroleptic malignant syndrome","volume":"72","author":"Susman","year":"2001","journal-title":"Psychiatric Quarterly"},{"issue":"9","key":"10.1002\/14651858.CD006271.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1089\/jpm.2013.0610","article-title":"Prescribing for nausea in palliative care: a cross-sectional national survey of Australian palliative medicine doctors","volume":"17","author":"To","year":"2014","journal-title":"Journal of Palliative Medicine"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0099|cit99","first-page":"39","article-title":"Nausea and vomiting in advanced cancer","volume":"5","author":"Twycross","year":"1998","journal-title":"European Journal of Palliative Care"},{"key":"10.1002\/14651858.CD006271.pub3-BIB0100|cit100","volume-title":"Palliative Care Formulary","author":"Twycross","year":"2014"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006271.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:47:57Z","timestamp":1784861277000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006271.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,2]]},"references-count":100,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006271.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,2]]}}}